WESTBOROUGH, Mass. June 30 /PRNewswire/ -- Joseph B. Bolen, Ph.D., CSO of Millennium Pharmaceuticals, will chair the Focus on Cancer track IBC Life Sciences Drug Discovery & Development of Innovative Therapeutics Conference and Exhibition taking place August 4-7 at the World Trade Center Boston & Seaport Hotel in Boston, MA. The cancer track presentations will focus on therapies for Hematology, Lung Cancer, Blood Borne Cancers, and Clinical Biomarkers.
Bolen has confirmed academia speakers including: Kenneth C. Anderson, M.D., Dana Farber Cancer Institute, Harvard Medical School; Bruce E. Johnson, M.D., Dana-Farber Cancer Institute, Harvard Medical School, Brigham and Women's Hospital; Mark A. Israel, M.D., Dartmouth Medical School; Neal Rosen, M.D., Ph.D., Memorial Sloan-Kettering Cancer Center; Massimo Loda, M.D., Dana Farber Cancer Institute, Brigham & Women's Hospital, Harvard Medical School
Companies also giving technical conference presentations in this cancer track include Alnylam Pharmaceuticals, Amgen, Inc., ARIAD Pharmaceuticals Inc., ArQule, Inc., AstraZeneca R&D Boston, Bristol-Myers Squibb Company, Exelixis Inc, Genzyme Corporation, Infinity Pharmaceuticals, Inc, Merck Research Laboratories, Novartis Institutes for BioMedical Research, OncoMed Pharmaceuticals Inc, The Johnson & Johnson Family of Companies.
Additional conference sessions at Drug Discovery & Development of
Innovative Therapeutics conference include:
-- Cardio-Metabolic Disease Drug Discovery and Development
-- Translational Medicine/Research
-- Transforming Technologies
-- Anti-Infective Drug Discovery and Development
-- Neurodegenerative Disease Drug Discovery and Development
-- Inflammation in Drug Discovery and Development
-- Orphan Diseases: Fast-Tracking Orphan Drugs and Scientific Advances -- The Next Generation of Therapeutics: Emerging Biologics, Stem Cells and RNAi
IBC's Drug Discovery & Development of Innovative Therapeutics Conference and Exhibition is an international event that covers topics across multiple therapeutic areas. The event includes over 15 presentations from more than 200 speakers, 150 exhibitors, 13 interactive round table discussions and 4 keynote presentations. For more information please visit http://www.drugdisc.com.
About IBC Life Sciences
IBC Life Sciences is the worldwide leader in scientific, technological
and business conferences and courses for the life science industry. To
develop its programs, IBC actively researches the advancements,
technologies and trends impacting and driving the race for new drugs and
therapies. No other organization can make claim to the breadth and quality
that IBC Life Sciences delivers in each event giving the company
recognition around the globe for quality, service and value. For more
information, visit: http://www.IBCLifeSciences.com.
Contact: Keri Dostie
IBC Life Sciences
|SOURCE IBC Life Sciences|
Copyright©2008 PR Newswire.
All rights reserved